These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 25490275)

  • 1. Sclerostin levels and changes in bone metabolism after bariatric surgery.
    Muschitz C; Kocijan R; Marterer C; Nia AR; Muschitz GK; Resch H; Pietschmann P
    J Clin Endocrinol Metab; 2015 Mar; 100(3):891-901. PubMed ID: 25490275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Vitamin D, Calcium, Protein Supplementation, and Physical Exercise on Bone Metabolism After Bariatric Surgery: The BABS Study.
    Muschitz C; Kocijan R; Haschka J; Zendeli A; Pirker T; Geiger C; Müller A; Tschinder B; Kocijan A; Marterer C; Nia A; Muschitz GK; Resch H; Pietschmann P
    J Bone Miner Res; 2016 Mar; 31(3):672-82. PubMed ID: 26350034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Roux-en-Y gastric bypass and sleeve gastrectomy on bone mineral density and marrow adipose tissue.
    Bredella MA; Greenblatt LB; Eajazi A; Torriani M; Yu EW
    Bone; 2017 Feb; 95():85-90. PubMed ID: 27871812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship with bone turnover.
    Gifre L; Ruiz-Gaspà S; Monegal A; Nomdedeu B; Filella X; Guañabens N; Peris P
    Bone; 2013 Nov; 57(1):272-6. PubMed ID: 23981659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Gastric Bypass and Gastric Banding on Bone Remodeling in Obese Patients With Type 2 Diabetes.
    Yu EW; Wewalka M; Ding SA; Simonson DC; Foster K; Holst JJ; Vernon A; Goldfine AB; Halperin F
    J Clin Endocrinol Metab; 2016 Feb; 101(2):714-22. PubMed ID: 26600045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients.
    Cejka D; Jäger-Lansky A; Kieweg H; Weber M; Bieglmayer C; Haider DG; Diarra D; Patsch JM; Kainberger F; Bohle B; Haas M
    Nephrol Dial Transplant; 2012 Jan; 27(1):226-30. PubMed ID: 21613383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of recent spinal cord injury on wnt signaling antagonists (sclerostin and dkk-1) and their relationship with bone loss. A 12-month prospective study.
    Gifre L; Vidal J; Carrasco JL; Filella X; Ruiz-Gaspà S; Muxi A; Portell E; Monegal A; Guañabens N; Peris P
    J Bone Miner Res; 2015 Jun; 30(6):1014-21. PubMed ID: 25484108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ibandronate increases sclerostin levels and bone strength in male patients with idiopathic osteoporosis.
    Muschitz C; Kocijan R; Pahr D; Patsch JM; Amrein K; Misof BM; Kaider A; Resch H; Pietschmann P
    Calcif Tissue Int; 2015 Jun; 96(6):477-89. PubMed ID: 25911186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral density.
    Voskaridou E; Christoulas D; Plata E; Bratengeier C; Anastasilakis AD; Komninaka V; Kaliontzi D; Gkotzamanidou M; Polyzos SA; Dimopoulou M; Terpos E
    Horm Metab Res; 2012 Nov; 44(12):909-13. PubMed ID: 22581647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with sclerosteosis and disease carriers: human models of the effect of sclerostin on bone turnover.
    van Lierop AH; Hamdy NA; Hamersma H; van Bezooijen RL; Power J; Loveridge N; Papapoulos SE
    J Bone Miner Res; 2011 Dec; 26(12):2804-11. PubMed ID: 21786318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bariatric Roux-En-Y Gastric Bypass Surgery: Adipocyte Proteins Involved in Increased Bone Remodeling in Humans.
    Biagioni MFG; Mendes AL; Nogueira CR; Leite CV; Gollino L; Mazeto GM
    Obes Surg; 2017 Jul; 27(7):1789-1796. PubMed ID: 28091892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone Mineral Density and Turnover After Sleeve Gastrectomy and Gastric Bypass: A Randomized Controlled Trial (Oseberg).
    Hofsø D; Hillestad TOW; Halvorsen E; Fatima F; Johnson LK; Lindberg M; Svanevik M; Sandbu R; Hjelmesæth J
    J Clin Endocrinol Metab; 2021 Jan; 106(2):501-511. PubMed ID: 33150385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise Mitigates Bone Loss in Women With Severe Obesity After Roux-en-Y Gastric Bypass: A Randomized Controlled Trial.
    Murai IH; Roschel H; Dantas WS; Gil S; Merege-Filho C; de Cleva R; de Sá-Pinto AL; Lima F; Santo MA; Benatti FB; Kirwan JP; Pereira RM; Gualano B
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4639-4650. PubMed ID: 31322672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in bone metabolism after bariatric surgery by gastric bypass or sleeve gastrectomy.
    Ivaska KK; Huovinen V; Soinio M; Hannukainen JC; Saunavaara V; Salminen P; Helmiö M; Parkkola R; Nuutila P; Kiviranta R
    Bone; 2017 Feb; 95():47-54. PubMed ID: 27818311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower fracture risk in older men with higher sclerostin concentration: a prospective analysis from the MINOS study.
    Szulc P; Bertholon C; Borel O; Marchand F; Chapurlat R
    J Bone Miner Res; 2013 Apr; 28(4):855-64. PubMed ID: 23165952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulated serum sclerostin level in the T2DM patients with femur fracture inhibits the expression of bone formation/remodeling-associated biomarkers via antagonizing Wnt signaling.
    Wu Y; Xu SY; Liu SY; Xu L; Deng SY; He YB; Xian SC; Liu YH; Ni GX
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):470-478. PubMed ID: 28239825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial.
    Anastasilakis AD; Polyzos SA; Gkiomisi A; Bisbinas I; Gerou S; Makras P
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3206-12. PubMed ID: 23788684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aromatase inhibition on serum levels of sclerostin and dickkopf-1, bone turnover markers and bone mineral density in women with breast cancer.
    Kyvernitakis I; Rachner TD; Urbschat A; Hars O; Hofbauer LC; Hadji P
    J Cancer Res Clin Oncol; 2014 Oct; 140(10):1671-80. PubMed ID: 24903965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus.
    van Lierop AH; Hamdy NA; van der Meer RW; Jonker JT; Lamb HJ; Rijzewijk LJ; Diamant M; Romijn JA; Smit JW; Papapoulos SE
    Eur J Endocrinol; 2012 Apr; 166(4):711-6. PubMed ID: 22267280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INCREASED BONE TURNOVER IN TYPE 2 DIABETES PATIENTS RANDOMIZED TO BARIATRIC SURGERY VERSUS MEDICAL THERAPY AT 5 YEARS.
    Crawford MR; Pham N; Khan L; Bena JF; Schauer PR; Kashyap SR
    Endocr Pract; 2018 Mar; 24(3):256-264. PubMed ID: 29144812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.